News
Important Only
Biote Corp expected to post earnings of 7 cents a share - Earnings Preview
Biote Corp BTMD.OQ BTMD.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Irving Texas-based company is expected to report a 0.4% increase in revenue to $46.985 million from $46.8 million a year ago, according to the mean esti...Reuters
Mon, May 5
Turkish bank appeals Iran sanctions decision to US Supreme Court
By Jonathan Stempel NEW YORK, May 5 (Reuters) - Turkey's Halkbank HALKB.IS asked the U.S. Supreme Court to review a lower court ruling saying it can be prosecuted for allegedly helping Iran evade American sanctions, a U.S.-based lawyer for the bank said on Monday.The Supreme Court had given H...Reuters
Mon, May 5
Uber And WeRide Expand Strategic Partnership To Bring Autonomous Vehicles To 15 More Cities
May 5 (Reuters) - Uber Technologies Inc UBER.N:UBER :CO, WERIDE EXPAND STRATEGIC PARTNERSHIP TO BRING AUTONOMOUS VEHICLES TO 15 ADDITIONAL CITIES GLOBALLY OVER NEXT 5 YEARS, INCLUDING IN EUROPEReuters
Mon, May 5
Alta Equipment Group Inc expected to post a loss of 62 cents a share - Earnings Preview
Alta Equipment Group Inc ALTG.N, ALTG.K is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Livonia Michigan-based company is expected to report a 1.2% decrease in revenue to $436.138 million from $441.6 million a year ago, accord...Reuters
Mon, May 5
LivePerson Inc expected to post a loss of 24 cents a share - Earnings Preview
LivePerson Inc LPSN.OQ LPSN.O is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The New York City-based company is expected to report a 24.5% decrease in revenue to $64.255 million from $85.15 million a year ago, according to the me...Reuters
Mon, May 5
Structure Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Structure Therapeutics Inc GPCR.OQ GPCR.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Structure Therapeutics Inc is for a loss of 23 cents per share. The current average anal...Reuters
Mon, May 5
Root Inc expected to post earnings of 34 cents a share - Earnings Preview
Root Inc ROOT.OQ ROOT.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Columbus Ohio-based company is expected to report a 22.9% increase in revenue to $313.279 million from $254.9 million a year ago, according to the mean es...Reuters
Mon, May 5
Crombie Real Estate Investment Trust expected to post a share - Earnings Preview
Crombie Real Estate Investment Trust CRR_u.TO is expected to report results on May 7 for the period ending March 31 2025LSEG's mean analyst estimate for Crombie Real Estate Investment Trust is for earnings of 31 cents per share. The current average analyst rating on the shares is "buy"...Reuters
Mon, May 5
CS Disco Inc expected to post a loss of 11 cents a share - Earnings Preview
CS Disco Inc LAW.N, LAW is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Austin Texas-based company is expected to report a 1.5% increase in revenue to $36.121 million from $35.57 million a year ago, according to the mean estim...Reuters
Mon, May 5
Tectonic Therapeutic Inc expected to post a loss of $1.09 a share - Earnings Preview
Tectonic Therapeutic Inc TECX.OQ TECX.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Tectonic Therapeutic Inc is for a loss of $1.09 per share. The current average analyst rating on the shares is "buy" and the brea...Reuters
Mon, May 5
Trump signs order restricting research that enhances pathogens
WASHINGTON, May 5 (Reuters) - U.S. President Donald Trump signed an executive order on Monday that bans federal funding for gain-of-function research that typically enhances pathogens.The order also paused any research using "infectious pathogens and toxins in the United States" that could b...Reuters
Mon, May 5
Bristol Myers to invest $40 billion in the US over 5 years, CEO says
May 5 (Reuters) - Bristol Myers Squibb BMY.N will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion piece published by Stat News on Monday.The money will be spread across research and development, technology and domestic manufacturing, Boerner said.Reuters
Mon, May 5
Xenetic Biosciences Inc expected to post a loss of 72 cents a share - Earnings Preview
Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected to show a rise in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Framingham Massachusetts-based company is expected to report a 31.2% increase in revenue to $670 thousand from $510.82 thousand...Reuters
Mon, May 5
Trump to continue Biden's court defense of abortion drug mifepristone
Government lawyers seek dismissal of lawsuitRepublican-led states challenge easier access to abortion drugUS Supreme Court rejected challenge by anti-abortion groupsBy Daniel Wiessner May 5 (Reuters) - President Donald Trump's administration on Monday pushed forward in defending U.S. rules ea...Reuters
Mon, May 5
Smith Micro Software Inc expected to post a loss of 11 cents a share - Earnings Preview
Smith Micro Software Inc SMSI.OQ SMSI.O is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Pittsburgh Pennsylvania-based company is expected to report a 10.2% decrease in revenue to $5.209 million from $5.8 million a year ago, ac...Reuters
Mon, May 5
